Physician
Bay Pediatric Center
Bay Pediatric Center was paid $10.80M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoBAY PEDIATRIC CENTER
EASTON, MD 21601
EASTON, MD 21601
33aNPI1730204827assigned 03/20/2007
33bProvider typePediatrics Physician
28Total paid$10.80M
24GClaims164,945
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#7 of 306
Median peer was paid$206K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 293 | $7K | |
| 2019 | 440 | $11K | |
| 2020 | 27,353 | $1.58M | |
| 2021 | 30,957 | $2.24M | |
| 2022 | 37,719 | $2.69M | |
| 2023 | 34,403 | $2.33M | |
| 2024incomplete | 33,780 | $1.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 36,286 | 31,575 | $3.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 25,962 | 21,817 | $3.05M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.9% | 5,990 | 5,460 | $632K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.8% | 1,564 | 1,379 | $520K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.7% | 5,298 | 4,500 | $508K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 4,790 | 4,430 | $505K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 4.5% | 3,697 | 3,256 | $484K |
| 92587 | 3.3% | 16,111 | 14,609 | $357K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 3,016 | 2,664 | $338K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.7% | 2,075 | 1,979 | $286K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 6,421 | 5,750 | $189K |
| 90670 | 1.5% | 2,062 | 1,909 | $165K |
59 more codes
| 90686 | <1% | 4,787 | $96K | |
| D1206 | Topical application of fluoride varnish | <1% | 2,744 | $68K |
| 95930 | <1% | 801 | $57K | |
| 87486 | <1% | 1,567 | $44K | |
| 87581 | <1% | 1,564 | $44K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,563 | $43K |
| 92567 | <1% | 2,442 | $39K | |
| 90677 | <1% | 388 | $35K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 182 | $29K |
| 96127 | <1% | 5,212 | $23K | |
| 90723 | <1% | 1,095 | $22K | |
| 90647 | <1% | 996 | $21K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,783 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 299 | $16K |
| 96160 | <1% | 5,665 | $14K | |
| 99177 | <1% | 2,945 | $14K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 686 | $14K |
| 87631 | <1% | 112 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 362 | $11K |
| 90656 | <1% | 382 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 93 | $7K |
| 81002 | <1% | 2,435 | $7K | |
| 90633 | <1% | 327 | $7K | |
| 90734 | <1% | 216 | $4K | |
| 0002A | <1% | 104 | $4K | |
| 90681 | <1% | 190 | $4K | |
| 90651 | <1% | 183 | $4K | |
| 83655 | <1% | 321 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 252 | $3K |
| 90661 | <1% | 108 | $3K | |
| 81025 | <1% | 383 | $3K | |
| 0001A | <1% | 63 | $2K | |
| A4558 | Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz | <1% | 819 | $2K |
| 83718 | <1% | 301 | $2K | |
| 85018 | <1% | 831 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 34 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 600 | $1K |
| 0072A | <1% | 31 | $1K | |
| 87807 | <1% | 99 | $1K | |
| 0071A | <1% | 31 | $1K | |
| 82465 | <1% | 304 | $1K | |
| 90620 | <1% | 48 | $933.57 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 71 | $926.12 |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 778 | $725.40 |
| 90715 | <1% | 19 | $419.04 | |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 253 | $125.55 |
| 81003 | <1% | 50 | $104.06 | |
| 94760 | <1% | 75 | $73.59 | |
| 94664 | <1% | 14 | $68.81 | |
| 99051 | <1% | 37 | $51.33 | |
| 97802 | <1% | 20 | $25.00 | |
| A6411 | Eye pad, non-sterile, each | <1% | 826 | $16.39 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 249 | $9.85 |
| 99072 | 0% | 379 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 18 | $0.00 |
| 3008F | 0% | 3,922 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,503 | $0.00 |
| 99000 | 0% | 98 | $0.00 | |
| 99070 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMASON, ELIZABETH (MANAGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Steinway NY Medical Assoc PLLC | Astoria, NY | $641K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.